Download Files:
TRC160334
SKU
HY-141625-10 mg
Category Reference compound
Tags HIF/HIF Prolyl-Hydroxylase, Metabolic Enzyme/Protease, Others
$290 – $2,250
Products Details
Product Description
– TRC160334 is a hypoxia-inducible factor (HIF) hydroxylase inhibitor. TRC160334 can be used for the research of ischemia/reperfusion injury[1].
Web ID
– HY-141625
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Metabolism-sugar/lipid metabolism
Molecular Formula
– C14H15N3O5S
References
– [1]Jamadarkhana P, et al. Treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates ischemic acute kidney injury. Am J Nephrol. 2012;36(3):208-218.
CAS Number
– 1293289-69-6
Molecular Weight
– 337.35
Compound Purity
– 95.0
SMILES
– O=C(C1=C(O)N=C(SC2=C3CCCCC2)N3C1=O)NCC(O)=O
Clinical Information
– No Development Reported
Research Area
– Others
Solubility
– DMSO : 25 mg/mL (ultrasonic;warming;heat to 80°C)
Target
– HIF/HIF Prolyl-Hydroxylase
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.